Skip to main content
. 2015 May 28;90(7):577–583. doi: 10.1002/ajh.24040

Figure 1.

Figure 1

Mean changes from baseline in the ITT (n = 10) and completer (n = 8) cohorts in hemoglobin concentration and platelet count. Baseline was defined as before the first dose in the phase I/II trial. For the ITT analysis, imputation was applied to missing data. For the completer group analysis, imputation was not applied to missing data. In the completer group, n = 6 at 84 months.